Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
139,138,306
-
Shares change
-
-323,842
-
Total reported value, excl. options
-
$1,913,174,245
-
Value change
-
-$6,784,614
-
Put/Call ratio
-
92.14%
-
Number of buys
-
90
-
Number of sells
-
-81
-
Price
-
$13.75
Significant Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q1 2016
212 filings reported holding NKTR - Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2016.
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 139,138,306 shares
.
Largest 10 shareholders include OppenheimerFunds, Inc. (26,007,761 shares), PRIMECAP MANAGEMENT CO/CA/ (20,010,086 shares), VANGUARD GROUP INC (11,349,223 shares), BlackRock Fund Advisors (10,029,475 shares), Camber Capital Management LLC (4,500,000 shares), Invesco Ltd. (4,422,402 shares), BRIDGER MANAGEMENT, LLC (3,517,011 shares), STATE STREET CORP (3,480,120 shares), BlackRock Institutional Trust Company, N.A. (3,270,963 shares), and RA CAPITAL MANAGEMENT, LLC (3,178,854 shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.